131 related articles for article (PubMed ID: 6142449)
1. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
Weber RW; Nelson HS
Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
[TBL] [Abstract][Full Text] [Related]
3. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
Richards DM; Brogden RN
Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
[TBL] [Abstract][Full Text] [Related]
4. Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'.
Derksen FJ; Olszewski M; Robinson NE; Berney C; Lloyd JW; Hakala J; Matson C; Ruth D
Equine Vet J; 1996 Jul; 28(4):306-10. PubMed ID: 8818596
[TBL] [Abstract][Full Text] [Related]
5. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
[TBL] [Abstract][Full Text] [Related]
6. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.
MacNee W; Wathen CG; Hannan WJ; Flenley DC; Muir AL
Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1169-72. PubMed ID: 6138118
[TBL] [Abstract][Full Text] [Related]
7. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler.
Völkl KP; Kroll VM; Wiesemann HG; Schneider B
Arzneimittelforschung; 1991 May; 41(5):533-6. PubMed ID: 1680327
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
[TBL] [Abstract][Full Text] [Related]
10. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.
Colucci WS; Alexander RW; Williams GH; Rude RE; Holman BL; Konstam MA; Wynne J; Mudge GH; Braunwald E
N Engl J Med; 1981 Jul; 305(4):185-90. PubMed ID: 6113543
[TBL] [Abstract][Full Text] [Related]
11. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
Weber KT; Andrews V; Janicki JS; Likoff M; Reichek N
Circulation; 1982 Dec; 66(6):1262-7. PubMed ID: 6128086
[TBL] [Abstract][Full Text] [Related]
12. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
Dawson JR; Canepa-Anson R; Kuan P; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Sep; 50(3):282-9. PubMed ID: 6137226
[TBL] [Abstract][Full Text] [Related]
13. Effects of the beta-adrenergic receptor agonist pirbuterol on cardiac performance during acute ischaemic left ventricular failure in dogs.
Smiseth OA
Eur J Pharmacol; 1983 Mar; 87(4):379-86. PubMed ID: 6133759
[TBL] [Abstract][Full Text] [Related]
14. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
Uretsky BF; Seecof RM; Reddy PS
Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
[TBL] [Abstract][Full Text] [Related]
15. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
Canepa-Anson R; Dawson JR; Kuan P; Warnes CA; Poole-Wilson PA; Reuben SR; Sutton GC
Am Heart J; 1981 Sep; 102(3 Pt 2):578-83. PubMed ID: 6115575
[No Abstract] [Full Text] [Related]
16. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure.
Colucci WS; Alexander RW; Mudge GH; Rude RE; Holman BL; Wynne J; Grossman W; Braunwald E
Am Heart J; 1981 Sep; 102(3 Pt 2):564-8. PubMed ID: 6115573
[No Abstract] [Full Text] [Related]
17. Double-blind, clinical efficacy study comparing 400 micrograms of pirbuterol versus placebo delivered by a breath-actuated aerosol inhaler.
Tinkelman DG; Vanden Burgt JA; Ekholm BP
J Asthma; 1994; 31(3):187-92. PubMed ID: 7910819
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
[TBL] [Abstract][Full Text] [Related]
19. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
[TBL] [Abstract][Full Text] [Related]
20. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
Dyson AJ; Mackay AD
Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
